NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
Mar 22, 2021 $4.11 $4.15 $3.97 $3.97 457 993
Mar 19, 2021 $4.04 $4.42 $3.95 $4.04 1 721 898
Mar 18, 2021 $4.08 $4.54 $3.95 $3.96 2 717 756
Mar 17, 2021 $3.93 $4.20 $3.80 $4.14 776 452
Mar 16, 2021 $4.22 $4.23 $3.91 $4.02 840 393
Mar 15, 2021 $4.30 $4.38 $4.02 $4.26 2 122 549
Mar 12, 2021 $3.63 $4.59 $3.58 $4.40 6 693 608
Mar 11, 2021 $4.09 $4.34 $3.77 $4.00 3 300 971
Mar 10, 2021 $4.41 $4.71 $4.05 $4.44 6 872 161
Mar 09, 2021 $4.45 $6.25 $4.16 $5.20 58 511 897
Mar 08, 2021 $3.20 $4.20 $3.20 $3.42 19 004 599
Mar 05, 2021 $2.89 $4.12 $2.70 $3.16 18 575 064
Mar 04, 2021 $3.05 $3.16 $2.70 $2.81 472 388
Mar 03, 2021 $3.35 $3.41 $3.02 $3.02 298 916
Mar 02, 2021 $3.45 $3.45 $3.20 $3.27 208 756
Mar 01, 2021 $3.20 $3.44 $3.20 $3.24 304 591
Feb 26, 2021 $3.12 $3.40 $2.92 $3.05 634 508
Feb 25, 2021 $3.63 $3.66 $3.20 $3.24 427 280
Feb 24, 2021 $3.39 $3.69 $3.35 $3.51 410 993
Feb 23, 2021 $3.71 $3.74 $3.06 $3.32 889 212
Feb 22, 2021 $3.97 $4.25 $3.75 $4.10 649 337
Feb 19, 2021 $4.25 $5.54 $4.02 $4.08 2 518 765
Feb 18, 2021 $4.23 $4.35 $3.92 $4.12 1 428 155
Feb 17, 2021 $3.66 $4.46 $3.56 $4.45 3 055 865
Feb 16, 2021 $3.69 $3.80 $3.52 $3.63 476 078
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT